Disclose significant factors that materially affected the issuer’s income from operations, including unusual or infrequent events or new developments and the extent to which income was affected by these
therapeutic possibilities, including rare diseases or extremely expensive, complex and long-term treatments; • Research to continually improve care and develop new treatments; • Training of doctors, midwives
Company’s authorized directors shall be empowered to consider, determine and modify other details which are necessary for and in relation to the allocation of the newly issued ordinary shares, including, but
person(s) designated by the Company’s authorized directors shall be empowered to consider, determine and modify other details which are necessary for and in relation to the allocation of the newly issued
Company’s authorized directors or any person(s) designated by the Company’s authorized directors shall be empowered to consider, determine and modify other details which are necessary for and in relation to
necessary, the SEC Office upon approval of the SEC may revise or modify the operating plan; in such regard, the provision in the first paragraph shall be applicable, mutatis mutandis. The operating plan of
5th day of November 2008. (Mr. Vijit Supinit) Chairman Securities and Exchange Commission Remarks : The reason for issuing this Notification is that it deems appropriate to modify the qualifications of
. Notified this 5th day of November 2008. (Mr. Vijit Supinit) Chairman Securities and Exchange Commission Remarks: The reason for issuing this Notification is that it deems appropriate to modify the
Entities to the extent possible under Domestic Law. 2. This MoU does not create any legally binding obligations, confer any rights on any Person, or modify or supersede any Domestic Law. 3. This MoU